Abstract
Staphylococcus aureus is the leading cause of surgical site infections (SSI) in the United States. In particular, SSI caused by methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a devastating complication, leading to increased mortality rates, increased length of hospitalization, and increased costs. Proven strategies for prevention of SSI caused by S aureus include addressing modifiable risk factors and correct choice and timing of antimicrobial prophylaxis. Other strategies, including decolonization and the use of vancomycin, remain controversial.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 53-72 |
| Number of pages | 20 |
| Journal | Infectious Disease Clinics of North America |
| Volume | 23 |
| Issue number | 1 |
| DOIs | |
| State | Published - Mar 2009 |
| Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Microbiology (medical)
- Infectious Diseases
Keywords
- Antimicrobial prophylaxis
- Epidemiology
- Surgical site infection
Fingerprint
Dive into the research topics of 'Staphylococcal Surgical Site Infections'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver